Menu Philippe 4

4 · SOPHiA GENETICS SA · Filed Mar 20, 2026

AI-generated summary of this filing

Updated Mar 20, 2026

SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 608 Shares

What Happened

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), reported the sale of 608 common shares on 2026-03-19. The weighted average sale price was $4.79, for a total transaction value of approximately $2,913. This was a sale (S) rather than a purchase.

Key Details

Transaction date: 2026-03-19; Form 4 filed: 2026-03-20 (appears timely).
Reported weighted average price: $4.79; individual sale prices ranged from $4.73 to $4.87 (footnote F2).
Reason: Shares were sold to satisfy tax obligations related to restricted stock units vesting on 2026-03-18; sales were made under a pre-established Rule 10b5-1 trading plan and were non‑discretionary (footnote F1).
Shares owned after the transaction: not stated in the provided filing excerpt.
Filing accession: 0001840706-26-000069.

Context

This sale was conducted to cover tax withholding from RSU vesting and executed under a 10b5-1 plan, which typically indicates a pre-planned, non-discretionary disposition. Such routine tax‑related sales are common and generally less indicative of a change in insider sentiment than voluntary open‑market purchases. The filer offers to provide a breakdown of shares sold at each separate price within the reported range upon written request (per F2).

Form 4

Period: 2026-03-19

Chief Medical Officer

Transactions

Footnotes (2)

[F1]Represents shares sold by the Reporting Person in the open market to satisfy tax obligations arising in connection with the vesting of restricted stock units on March 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-03-20

1 file